1 UCM Digestive Diseases and Ciberehd. Virgen del Rocío University Hospital, Spain mromerogomez@us.es.
2 Institute of Biomedicine of Seville (HUVR/CSIC/US), Spain.
3 Department of Medicine, University of Seville, Seville, Spain.
4 School of Public Health, University of Haifa, Haifa, Israel.
5 Department of Gastroenterology, Tel-Aviv Medical Center, Tel-Aviv, Israel.
6 Andalusian Center of Molecular Biology and Regenerative Medicine (CABIMER), Pablo de Olavide University, University of Seville, Spain.
7 Biomedical Research Network on Diabetes and Related Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
8 Department of Medical Sciences, University of Turin, Turin, Italy.
9 Division of Gastroenterology, Città Della Salute e Della Scienza University-Hospital, Turin, Italy.
10 Unit of Advanced Therapies and Regenerative Medicine, Health Research Institute of the Dr Balmis University Hospital of Alicante (ISABIAL), Institute of Bioengineering University Miguel Hernández, CIBERDEM, Instituto de Salud Carlos III, Madrid, Spain.
Manuel Romero-Gómez and colleagues discuss how diet and modifiable factors can help prevent of non-alcoholic fatty liver disease and the importance of engaging all society through awareness, education, and policy change
MeSH terms
Humans
Liver
Non-alcoholic Fatty Liver Disease* / prevention & control